A recent survey of state IT authorities reveals how states currently use generative AI in production. Artificial Intelligence in State Government IT Operations, published by the National Association of State Technology Directors distributed their survey to IT authorities in all 50 states in May 2024. With 42 states responding, survey results of GenAI use included chatbots (50%), office productivity (36%) and code development (26%).
A report aimed at helping counties integrate artificial intelligence into their operations offers useful advice for all levels of government to follow. The AI County Compass: A Comprehensive Toolkit for Local Governance and Implementation of Artificial Intelligence, created by the National Association of Counties, takes readers from understanding key GenAI terms to strategizing next steps in their GenAI journey. NACo’s AI committee co-chairs explain in the July 8 report that “four key themes emerged during our committee’s year-long exploration of generative artificial intelligence: Preparing the Workforce, Establishing an Ethical Framework, Promoting Policy Models, and Enabling Responsible Applications.”
Vermont’s Office of Professional Regulation issued a statement that IV therapy clinics “constitute the practice of medicine” and must follow rules related to prescriptions, drug compounding and administering IV’s. The OPR explained that the therapy involves an IV “cocktail” of saline and additives, such as vitamins, minerals or prescription medication to treat fatigue, dehydration and more, according to the Burlington Free Press on August 13. A statement from the OPR, along with the boards of medical practice, nursing, osteopathic medicine and pharmacy explained: “all IV fluids, even plain saline, are considered prescription drugs, and mixing in additives is known as ‘compounding,’ which invokes strong regulations.